Home › Deep Vein Thrombosis › Texas
Deep Vein Thrombosis clinical trials in Texas
7 studies for Deep Vein Thrombosis are looking for participants at sites in Texas.
Cities in Texas
REGN7508 in Adult Participants for Prevention of Cancer-Associated Thrombosis
- El Paso Medical Research Institute (Medresearch Inc), El Paso
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 29, 2026 · NCT07410117REGN7508 Versus Acetylsalicylic Acid (ASA) for Venous Thromboprophylaxis After Total Knee Arthroplasty in Adult Participants
- NextStage Clinical Research, All American Orthopedics and Sports Medicine, Houston
- Flourish Research - San Antonio (Formerly Clinical Trials of Texas), San Antonio
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT07213778Perivenous Dexamethasone Therapy: Examining Reduction of Inflammation After Thrombus Removal to Yield Benefit in Acute Femoropopliteal DVT
- HCA Medical City Arlington, Arlington
- HCA Houston Healthcare Medical Center, Houston
- Baylor Scott & White Hospital, Plano
RecruitingPhase 2
Ages 18 to 89 · All sexes · Updated Sep 25, 2026 · NCT04862468DEFIANCE: RCT of ClotTriever System Versus Anticoagulation In Deep Vein Thrombosis
- Clements University Hospital (UTSW), Dallas
Recruiting
Ages 18 and older · All sexes · Updated Sep 9, 2026 · NCT05701917Case-Specific Health Care Professional Clinical Survey of Liberant™ Thrombectomy System
- Baylor Heart Hospital Of Plano, Plano
RecruitingObservational study
Ages 22 and older · All sexes · Updated Aug 11, 2026 · NCT07335341Cleaner Long-tErm Assessment Registry - Venous Insights and Efficacy With eXtended Tracking
- Baylor Scott & White The Heart Hospital - Plano, Plano
RecruitingObservational study
Ages 18 and older · All sexes · Updated Jun 16, 2026 · NCT07102160Catheter-Related Early Thromboprophylaxis With Enoxaparin Studies
- Dell Children's Medical Canter, Austin
- UTSW Medical Center; Children's Medical Center of Dallas, Dallas
RecruitingPhase 2/3
Up to age 17 · All sexes · Updated Jun 8, 2026 · NCT04924322From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.